<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 01 Feb 2021 07:56:51 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>CD33靶向双特异性抗体的开发现状</title><link>https://mp.weixin.qq.com/s/3-YGrKyCuCfWj4EghgUaVA</link><description></description><content:encoded><![CDATA[CD33靶向双特异性抗体的开发现状]]></content:encoded><pubDate>Mon, 01 Feb 2021 06:00:46 +0800</pubDate></item><item><title>抗SARS-CoV-2中和抗体的临床进展</title><link>https://mp.weixin.qq.com/s/E2nU4_JCqWT-1B9RU2XgPw</link><description></description><content:encoded><![CDATA[抗SARS-CoV-2中和抗体的临床进展]]></content:encoded><pubDate>Fri, 29 Jan 2021 05:58:32 +0800</pubDate></item><item><title>IL-2和IL-15的肿瘤免疫中的调节作用及其应用前景</title><link>https://mp.weixin.qq.com/s/-ClKHlzksg4gmKxOlpCl3w</link><description></description><content:encoded><![CDATA[IL-2和IL-15的肿瘤免疫中的调节作用及其应用前景]]></content:encoded><pubDate>Mon, 25 Jan 2021 06:03:44 +0800</pubDate></item><item><title>阿斯利康PD-1/CTLA-4双抗，增强对PD-1+活化T细胞CTLA-4的阻断作用</title><link>https://mp.weixin.qq.com/s/3-R40BwBpwWnxayCI_VeIA</link><description></description><content:encoded><![CDATA[阿斯利康PD-1/CTLA-4双抗，增强对PD-1+活化T细胞CTLA-4的阻断作用]]></content:encoded><pubDate>Fri, 22 Jan 2021 06:24:29 +0800</pubDate></item><item><title>抗体药物的免疫原性</title><link>https://mp.weixin.qq.com/s/7Nk-fjXTh5kb9LVHqSmfTQ</link><description></description><content:encoded><![CDATA[抗体药物的免疫原性]]></content:encoded><pubDate>Mon, 18 Jan 2021 06:32:01 +0800</pubDate></item><item><title>盘点2020上市的抗体新药-（10）Margetuximab</title><link>https://mp.weixin.qq.com/s/dNwLQrVYAv8JxELzQLmyuw</link><description></description><content:encoded><![CDATA[盘点2020上市的抗体新药-（10）Margetuximab]]></content:encoded><pubDate>Fri, 15 Jan 2021 06:06:05 +0800</pubDate></item><item><title>靶向抗癌药物的免疫调节作用</title><link>https://mp.weixin.qq.com/s/8XzfqrcdfDK2jDlGpFaTGg</link><description></description><content:encoded><![CDATA[靶向抗癌药物的免疫调节作用]]></content:encoded><pubDate>Wed, 13 Jan 2021 06:16:02 +0800</pubDate></item><item><title>外周T细胞耐受：T细胞生命旅程中的检查点</title><link>https://mp.weixin.qq.com/s/VxT-Xs2BZC0WQV4ZIy-7BQ</link><description></description><content:encoded><![CDATA[外周T细胞耐受：T细胞生命旅程中的检查点]]></content:encoded><pubDate>Mon, 11 Jan 2021 06:11:05 +0800</pubDate></item><item><title>新的策略来定义Tregs！</title><link>https://mp.weixin.qq.com/s/bFKrwewARU7uqosb-O_wlg</link><description></description><content:encoded><![CDATA[新的策略来定义Tregs！]]></content:encoded><pubDate>Fri, 08 Jan 2021 06:28:14 +0800</pubDate></item><item><title>求职，非诚勿扰，有意者联系本人</title><link>https://mp.weixin.qq.com/s/p2ZtxsL6eW64SZMj09rzCw</link><description></description><content:encoded><![CDATA[求职，非诚勿扰，有意者联系本人]]></content:encoded><pubDate>Tue, 05 Jan 2021 08:16:04 +0800</pubDate></item></channel></rss>